ALTO-300 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 4mo
ESTIMATED |
READOUT
Study of ALTO-300 in MDD
Phase 2 · Major Depressive Disorder |
ANRO Alto Neuroscience, Inc. | ALTO-300 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|